Biocartis Group Nv Stock Shares Owned By Institutions
| BCART Stock | EUR 0.29 0.00 0.00% |
Biocartis Group NV fundamentals help investors to digest information that contributes to Biocartis Group's financial success or failures. It also enables traders to predict the movement of Biocartis Stock. The fundamental analysis module provides a way to measure Biocartis Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biocartis Group stock.
Biocartis |
Biocartis Group NV Company Shares Owned By Institutions Analysis
Biocartis Group's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Biocartis Group Shares Owned By Institutions | 27.71 % |
Most of Biocartis Group's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biocartis Group NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 27.706% of Biocartis Group NV are shares owned by institutions. This is 37.93% lower than that of the Health Care Equipment & Supplies sector and 48.49% lower than that of the Health Care industry. The shares owned by institutions for all Belgium stocks is 29.34% higher than that of the company.
Biocartis Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biocartis Group's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biocartis Group could also be used in its relative valuation, which is a method of valuing Biocartis Group by comparing valuation metrics of similar companies.Biocartis Group is currently under evaluation in shares owned by institutions category among its peers.
Biocartis Fundamentals
| Return On Equity | -48.84 | |||
| Return On Asset | -0.22 | |||
| Profit Margin | (1.07) % | |||
| Operating Margin | (0.85) % | |||
| Current Valuation | 182.31 M | |||
| Shares Outstanding | 93.1 M | |||
| Shares Owned By Insiders | 6.66 % | |||
| Shares Owned By Institutions | 27.71 % | |||
| Price To Earning | (9.91) X | |||
| Price To Book | 6.47 X | |||
| Price To Sales | 0.89 X | |||
| Revenue | 48.27 M | |||
| Gross Profit | (25.72 M) | |||
| EBITDA | (52.55 M) | |||
| Net Income | (71.47 M) | |||
| Cash And Equivalents | 53.52 M | |||
| Cash Per Share | 0.93 X | |||
| Total Debt | 128.15 M | |||
| Debt To Equity | 40.40 % | |||
| Current Ratio | 2.82 X | |||
| Book Value Per Share | (1.07) X | |||
| Cash Flow From Operations | (65.72 M) | |||
| Earnings Per Share | (1.24) X | |||
| Target Price | 1.8 | |||
| Number Of Employees | 619 | |||
| Beta | 1.51 | |||
| Market Capitalization | 60.8 M | |||
| Total Asset | 142.48 M | |||
| Retained Earnings | (188 M) | |||
| Working Capital | 90 M | |||
| Current Asset | 118 M | |||
| Current Liabilities | 28 M | |||
| Z Score | -1.4 | |||
| Net Asset | 142.48 M |
About Biocartis Group Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biocartis Group NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocartis Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocartis Group NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Biocartis Group
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocartis Group position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocartis Group will appreciate offsetting losses from the drop in the long position's value.Moving against Biocartis Stock
The ability to find closely correlated positions to Biocartis Group could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocartis Group when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocartis Group - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocartis Group NV to buy it.
The correlation of Biocartis Group is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocartis Group moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocartis Group NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocartis Group can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Biocartis Stock
Biocartis Group financial ratios help investors to determine whether Biocartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biocartis with respect to the benefits of owning Biocartis Group security.